Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis

NCT01996423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2015-03-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether oral vitamin D supplementation improves the clinical severity of atopic dermatitis in children. In addition, this study plans to evaluate the effects of vitamin D supplementation on several key aspects of the immune system of children with atopic dermatitis.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Pontificia Universidad Catolica de Chile

    lead OTHER

Principal Investigators

  • Arturo Borzutzky, M.D. · School of Medicine, Pontificia Universidad Católica de Chile

  • Carlos A Camargo Jr., M.D., DrPH · Massachusetts General Hospital, Harvard University, Boston, USA

  • Cristian Vera, M.D. · School of Medicine, Pontificia Universidad Católica de Chile

  • Lorena Cifuentes, M.D. · School of Medicine, Pontificia Universidad Católica de Chile

  • Sergio Silva, M.D. · School of Medicine, Pontificia Universidad Católica de Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Chile

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01996423 on ClinicalTrials.gov